New Delhi: Leucine, a pharma-based B2B startup, has raised $7 million as a part of Series A funding round led by Ecolab. The funding round witnessed participation from Pravega Ventures, Axilor Ventures, and other leading investors.
The pharma-based startup will be utilizing the funds to enhance its tech stack and revamp its existing AI capabilities.
The funds will also be used for expanding its team so that it can reach out to more customers easily and without any hassles.
In addition, the company has also announced the launch of Leucine10x, it’s an AI-based framework that will play a vital role in the pharmaceutical manufacturing process.
The company was co-founded by Vivek Gera and Mustaq Singh Bijral in 2019. Since its inception, Leucine has enabled pharmaceutical companies to use artificial intelligence to modernize manufacturing workflows by replacing conventional paper-based compliance procedures with a digital-first approach.
Vivek Gera, Cofounder and CEO of Leucine was quoted as saying, “We’re just scratching the surface; our vision is to leverage AI and technology to bring safe medicine to patients across the world.”
In addition, the company said that to date, its solutions have been deployed in over 30 companies in over 300 pharmaceutical manufacturing facilities across 10 countries, including the United States of America, India, Brazil, Mexico, and more.